Penfund Announces US$205 million Investment in DOCS Dermatology

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article contentTORONTO, March 04, 2026 (GLOBE NEWSWIRE) — Penfund, an independent provider of capital to North American middle market companies, announced the completion of a US$205 million unitranche loan to DOCS Dermatology Group (“DOCS” or the “Company”), a portfolio company of SkyKnight Capital (“SkyKnight”).Sign In or Create an AccountEmail AddressContinueor View more offersArticle contentFounded in 1978 and headquartered in Cincinnati, Ohio, DOCS is one of the largest dermatology platforms in the United States, with over 150 locations across 12 states. DOCS offers a range of clinical services, including general dermatology, Mohs surgery, dermatopathology, and cosmetic dermatology. DOCS provides its partner practices with centralized non-clinical resources and services that enable clinicians to focus on delivering best-in-class dermatological care to patients.Article contentWe apologize, but this video has failed to load.Try refreshing your browser, ortap here to see other videos from our team.Article contentArticle content“We are pleased to support DOCS in its next phase of growth. Dermatology is an attractive healthcare specialty with compelling long-term fundamentals, and DOCS is a high-quality, leading platform with a thoughtful growth strategy and a strong provider-centric culture,” stated Matthew Lee, a Partner at Penfund.Article contentTop StoriesGet the latest headlines, breaking news and columns.There was an error, please provide a valid email address.Sign UpBy signing up you consent to receive the above newsletter from Postmedia Network Inc.Thanks for signing up!A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againInterested in more newsletters? Browse here.Article contentMichael Binnington, a Partner at Penfund, added, “This transaction marks our first investment alongside SkyKnight, and we are pleased to establish a new partnership with their team. SkyKnight’s disciplined investment approach and collaborative style align with Penfund’s philosophy and the type of sponsor relationship we seek. We look forward to building upon this relationship and working together on future opportunities.”Article contentAbout DOCS Dermatology GroupArticle contentDOCS Dermatology Group is one of the largest dermatology practices in the United States, providing comprehensive medical, surgical, and cosmetic dermatology services. With a network of more than 150 locations, DOCS is dedicated to advancing skin health through clinical excellence, innovation, and patient-centered care. For more information, visit www.docsdermgroup.com.Article contentArticle contentAbout SkyKnight CapitalArticle contentSkyKnight Capital focuses on partnering with high quality businesses in acyclical growth sectors alongside exceptional management teams. SkyKnight manages over $4 billion in private equity capital on behalf of leading endowments, foundations, pensions, and institutional family offices. SkyKnight aims to build industry-defining businesses across the healthcare, financial services, and technology-enabled services industries. For more information, visit www.skyknightcapital.com.Article contentAbout PenfundArticle contentPenfund is a leading provider of capital to middle market companies throughout North America. The firm is actively investing both senior and junior capital through Penfund Prime and Penfund Capital Fund VII. Penfund manages funds sourced from pension funds, insurance companies, banks, family offices and high-net-worth individuals located in Canada, the United States, the Middle East, and Europe. Penfund has deployed more than C$4.3 billion in 75 investments since 2000. Assets under management are approximately C$3.5 billion. For more information, visit www.penfund.comArticle contentPenfund Contacts:Article contentRichard BradlowPartner(416) 645-3794richard@penfund.comArticle contentAdam BreslinPartner(416) 645-3796abreslin@penfund.comArticle contentJeremy ThompsonPartner(416) 645-3790jthompson@penfund.comArticle contentMichael BinningtonPartner(647) 776-2169mbinnington@penfund.comArticle contentMatthew LeePartner(647) 776-2165mlee@penfund.comArticle contentStephen VirgilioPartner(416) 645-3795svirgilio@penfund.comArticle contentArticle contentArticle contentArticle contentArticle contentArticle contentTrending Posthaste: This dormant pipeline needs to be restarted for the sake of Canada, economists say News Legal fight over propane terminal clouds Canada's energy export push Energy Canada’s Outstanding CEO of the Year: Canadian Tire chief Greg Hicks CEO of the Year Mortgage renewal headwinds near a ‘turning point’ for pandemic buyers, report says Mortgages Housing affordability improves yet again, though not for the right reasons Real Estate Share this article in your social networkCommentsYou must be logged in to join the discussion or read more comments.Create an AccountSign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information. Posthaste: This dormant pipeline needs to be restarted for the sake of Canada, economists say News Legal fight over propane terminal clouds Canada's energy export push Energy Canada’s Outstanding CEO of the Year: Canadian Tire chief Greg Hicks CEO of the Year Mortgage renewal headwinds near a ‘turning point’ for pandemic buyers, report says Mortgages Housing affordability improves yet again, though not for the right reasons Real Estate